computational biology News
-
CD ComputaBio Announces the Launch of IPA Analysis Service to Assist Drug Development
Recently, CD ComputaBio, a world-renowned computational biology services provider, announced the addition of IPA analysis service to all of its businesses. All along, the team of CD ComputaBio has been committed to using their accumulated knowledge and experience in computational biology for many years to continuously expand its services so as to help scientists around the world achieve ...
-
CD ComputaBio Introduces AutoDock, a Powerful Molecular Docking Software
CD ComputaBio, a reliable computational biology service provider in New York, is committed to assisting research and trials, as well as providing access to the latest software, technologies, and expertise at competitive prices and with fast turnarounds for researchers. The company is ready to support your molecular docking projects with its innovative AutoDock software. Autodock is an ...
-
CD ComputaBio Launches the In Silico PPI Prediction Service to Aid in Drug Action Mechanism Research
CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. Recently, the product manager announced the launch of the in silico protein-protein interactions prediction service to predict ...
-
CD Computabio Unleashes the Power of Computational Biology with Innovative Virtual Screening Service
CD Computabio, a prominent provider of computational biology solutions, is excited to introduce its virtual screening service based on pharmacophore fragments. This approach is poised to revolutionize the field of drug discovery by offering researchers an efficient and cost-effective solution for identifying promising drug candidates. In the early stages of drug development, virtual screening ...
-
CD ComputaBio Announces 3D-QSAR Service for Drug Design and Screening
CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company has recently launched 3D-QSAR services for scientists to accelerate the drug development process. Quantitative ...
-
CD ComputaBio Releases AutoDock Vina Software to Accelerate Molecular Docking Projects
CD ComputaBio, a reliable computational biology service provider in New York, is committed to assisting research and trials, as well as providing access to the latest software, technologies, and expertise with competitive prices and fast turnarounds for researchers. The company has recently announced the introduction of its Autodock Vina software, designed to predict the mechanism of small ...
-
CD ComputaBio Unveils Ligand-based Pharmacophore Model Service for Drug Design and Screening
CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering away at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company recently announced the launch of ligand-based pharmacophore model service for scientists to accelerate the ...
-
CD ComputaBio Boosts Your Disease Research with Computational Proteomics Service
CD ComputaBio, a reliable computational biology service provider in New York, is always committed to research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. CD ComputaBio offers dedicated computational proteomics service generating datasets with the required quality for ML/AI analysis, both ...
-
CD ComputaBio Boosts Small Molecule Drug Development with Protein-Small Molecule Docking Service
CD ComputaBio, a reliable computational biology service provider in New York, is committed to assisting research and trials, as well as providing access to the latest software, technologies, and expertise at competitive prices and with fast turnarounds for researchers. The company is pleased to announce the launch of the Protein-Small Molecule Docking service, designed to help customers quickly ...
-
CD ComputaBio Issues Global Simulations of Enzymatic Catalysis for Science Growth
After several years of experience accumulation, CD ComputaBio has grown into a professional provider of computational biology service in the world. Not long ago, CD ComputaBio announced the launch of global simulations of enzymatic catalysis for laboratories and research teams all over the world. The release of this service by CD ComputaBio will promote a big step forward in basic research ...
-
CD ComputaBio: A New Provider of Molecular Dynamics Simulation Service
CD ComputaBio is a well-known professional provider of computational biology services in the world, who has a senior research team and advanced experimental instruments. Last week, this company announced that it would introduce molecular dynamics simulation service to all scientists and researchers who want to accelerate drug research and development. This announcement marks the further ...
-
CD ComputaBio Unveils Cutting-Edge Advances in Antibody Drug Design and Development
Prominent within the field of computational biology, CD ComputaBio, unveils its cutting-edge Antibody Drug Design Services and Antibody Development solutions. Driven by an unwavering commitment to advancing precision medicine, the company stands at the forefront of redefining therapeutic strategies and expediting drug discovery processes, fostering innovation within the healthcare industry. In ...
-
CD ComputaBio Unveils Protein Structure Modeling Service for Drug Development
CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering away at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company recently announced the launch of protein structure modeling service to help researchers understand the ...
-
CD ComputaBio Introduces Four Docking Software for Drug Development
CD ComputaBio, a reliable computational service provider in the field of biology, is committed to assisting research and trials, as well as accessing the latest software, technologies, and expertise at a competitive price and fast turnaround for researchers. Molecular docking is a popular technique in drug design for predicting both binding patterns and binding affinity. CD ComputaBio has ...
-
Building a New Generation AI Engine and Jointly Accelerating World-Class Innovative Drug Discovery and Development
Regor Therapeutics Group and NVIDIA Corporation today entered into collaboration that makes Regor Therapeutics Group a unique biotech company in China to have in-depth access to NVIDIA Inception. Regor Therapeutics Group will work closely with NVIDIA to integrate high performance computing technology into Regor's proprietary Artificial Intelligence innovation platform - rCARDTM - to accelerate ...
-
Deep Genomics Appoints Veteran Ferdinand Massari as Chief Medical Officer
Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today that Ferdinand Massari, M.D., has been appointed Chief Medical Officer. Dr. Massari is based in Boston and will oversee clinical development and contribute to expanding the company’s AI platform and therapeutic portfolio. “In a short period of time, our artificial intelligence platform has ...
-
CD ComputaBio Introduces PyMOL Software for Bioinformatics Analysis
CD ComputaBio, a reliable computational biology service provider in New York, is committed to assisting research and trials, as well as providing access to the latest software, technologies, and expertise with competitive prices and fast turnarounds for researchers. The company has announced the introduction of the PyMOL software, a powerful utility for studying proteins, DNA, and other ...
-
Cancer Prevention and Early Detection Is One Step Closer as Universal DX Announces Breakthrough Study Results from Its Multi-omics + Computational Biology + Machine Learning Blood Tes
New results from the OMICS study, which will be presented atASCO, show Universal DX's blood test can detect colorectal cancer with extraordinary accuracy (92% sensitivity / 97% specificity), which exceeds currently available non-invasive tests for colorectal cancer screening Early detection cancer screening via a liquid biopsy is not only critical to save lives, but is a vast market opportunity, ...
-
Evofuel to participate in the 2019 International Castor Oil Association - ICOA Conference
Evofuel Ltd., a company focused on securing the global demand for stable castor oil supply and a wholly owned subsidiary of Evogene Ltd. (NASDAQ, TASE: EVGN), announced today that its CEO, Mr. Assaf Dotan, will present at 2019 ICOA Conference to take place on the 21st-23rd of May, 2019 in Dubrovnick, Croatia. Mr. Assaf Dotan will present the company’s new vision and branding. The ...
By Evogene Ltd.
-
Accelerating Drug Development with CD ComputaBio's Advanced Drug Design and CADD Solutions
CD ComputaBio, a reputable computational service provider in the field of biology, is dedicated to supporting research and trials by offering access to the latest software, technologies, and expertise at competitive prices and with fast turnaround times for researchers. Recently, the company introduced a series of state-of-the-art services in Drug Design and Computer-Aided Drug Design (CADD) with ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you